Literature DB >> 6795305

In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.

J T Rosenbaum, N E Adelman, H O McDevitt.   

Abstract

Immune response (Ir) gene products control immunologic function at several critical sites. We administered in vivo a monoclonal antibody reactive with I-Ak to F1 mice with the genotype H-2k/b. These treated mnice made a markedly reduced antibody response to antigen (H,G)-A--L, under the control of I-Ak, but not to antigen (T,G)-A--L, under the control of I-Ab. This relative specificity was lost if the antigen was given in complete Freund's adjuvant rather than aqueous solution. The monoclonal antibody reduced the antibody titer in an ongoing, secondary response as well. Several potential mechanisms can be postulated for this effect. This haplotypic specificity might ultimately be relevant to human disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795305      PMCID: PMC2186506          DOI: 10.1084/jem.154.5.1694

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera.

Authors:  R H Schwartz; C S David; D H Sachs; W E Paul
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

2.  Antigen specific T cell factors in the genetic control of the immune response to poly(tyr,glu)poly(pro)--poly(lys).

Authors:  E Mozes; R Isac
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

3.  Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

Authors:  M SELA; S FUCHS; R ARNON
Journal:  Biochem J       Date:  1962-10       Impact factor: 3.857

Review 4.  The association between genes in the major histocompatibility complex and disease susceptibility,.

Authors:  T Sasazuki; H O McDevitt; F C Grumet
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

Review 5.  A cardinal role for I-region antigens (Ia) in immunological enhancement, and the clinical implications.

Authors:  D A Davies; N A Staines
Journal:  Transplant Rev       Date:  1976

6.  Inhibition of immune responses in vitro by specific antiserums to Ia antigens.

Authors:  J A Frelinger; J E Niederhuber; D C Shreffler
Journal:  Science       Date:  1975-04-18       Impact factor: 47.728

7.  Genetic control of the immune response. A selective defect in immunologic (IgG) memory in nonresponder mice.

Authors:  F C Grumet
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

8.  Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex.

Authors:  T Tada; M Taniguchi; C S David
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

9.  Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT).

Authors:  P Debré; J A Kapp; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

10.  Alloantiserum-induced inhibition of immune response gene product function. II. Genetic analysis of target antigens.

Authors:  E M Shevach; I Green; W E Paul
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  20 in total

Review 1.  New therapeutic approaches to autoimmune disease.

Authors:  N Talal
Journal:  Springer Semin Immunopathol       Date:  1986

2.  The interaction of interdigitating cells and lymphocytes in vitro and in vivo.

Authors:  M Breel; R Mebius; G Kraal
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

3.  Mechanism of regulation of immune responses by in vivo administration of monoclonal anti-I-A antibodies.

Authors:  M I Greene; L Perry; A Carroll; A Lowy
Journal:  Surv Immunol Res       Date:  1985

4.  Monoclonal anti-Ia antibodies suppress the flare up reaction of antigen induced arthritis in mice.

Authors:  M F van den Broek; W B van den Berg; L B van de Putte
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

5.  Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.

Authors:  D Moskophidis; S P Cobbold; H Waldmann; F Lehmann-Grube
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

6.  In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products.

Authors:  C Boitard; S Michie; P Serrurier; G W Butcher; A P Larkins; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Anti-class II MHC antibodies prevent and treat EAE without APC depletion.

Authors:  R M Smith; A Morgan; D C Wraith
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

Review 8.  Suppressor mechanisms in tumor immunity.

Authors:  G T Nepom; I Hellström; K E Hellström
Journal:  Experientia       Date:  1983-03-15

9.  Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells.

Authors:  C Boitard; A Bendelac; M F Richard; C Carnaud; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.

Authors:  I Kato; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.